Law Daily Report

Congo trial of Ebola treatments switches to focus on two drugs

  • 📰 ChannelNewsAsia
  • ⏱ Reading Time:
  • 11 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 8%
  • Publisher: 66%

Law Law Headlines News

Law Law Latest News,Law Law Headlines

LONDON: A clinical trial of four potential Ebola treatments in Congo has been narrowed to focus on two of the experimental drugs: Regeneron's ...

LONDON: A clinical trial of four potential Ebola treatments in Congo has been narrowed to focus on two of the experimental drugs: Regeneron's REGN-EB3 and a monoclonal antibody called mAb114: after they showed encouraging results, scientists leading the trial said on Monday.

Two other experimental treatments - ZMapp, an intravenous treatment made by Mapp Biopharmaceutical and Remdesivir, made by Gilead Sciences, will now be dropped from the trial, the researchers said.

 

Thank you for your comment. Your comment will be published after being reviewed.
Please try again later.
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

 /  🏆 6. in LAW

Law Law Latest News, Law Law Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

Regeneron's Ebola treatment proves superior to rival in trialREUTERS: Regeneron Pharmaceuticals Inc said on Monday its experimental treatment for Ebola proved superior to a rival therapy from Mapp ...
Source: ChannelNewsAsia - 🏆 6. / 66 Read more »

Regeneron's Ebola treatment proves superior to rival in trialREUTERS: Regeneron Pharmaceuticals Inc said on Monday its experimental treatment for Ebola proved superior to a rival therapy from Mapp ...
Source: ChannelNewsAsia - 🏆 6. / 66 Read more »